The once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.
Health Canada approves 1st GLP-1 daily pill. Here’s who can take it
Published 8 hours ago
Source: globalnews.ca

Categories
CanadaHealthGLP-1Novo NordiskRybelsus
Related Articles from globalnews.ca
18 minutes ago
Snowmobile Safety Week kicks off for 2026 in Saskatchewan
25 minutes ago
Dinwiddie declares Brown as Redblacks’ starter
38 minutes ago
PetroChina meeting obstacles as it seeks to buy South Bow pipeline stake
1 hour ago
Pimicikamak chief says ‘about every house’ will need repair as military arrives
1 hour ago
Winnipegger pushes to ban 3rd-party obituary sites
1 hour ago